Literature DB >> 16433801

Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery.

B Stenquist1, M B Ericson, C Strandeberg, L Mölne, A Rosén, O Larkö, A M Wennberg.   

Abstract

BACKGROUND: Fluorescence imaging is an attractive diagnostic technique for skin tumour demarcation with potential to move to clinical use. Bispectral fluorescence imaging combines skin autofluorescence with delta-aminolaevulinic acid-induced fluorescence. To evaluate the technique, fluorescence data must be compared with the histopathological extent of the tumour, which is the purpose of the current study.
OBJECTIVES: To investigate the agreement between bispectral fluorescence images and the histopathological tumour boundary of ill-defined basal cell carcinomas (BCCs). After fluorescence imaging the tumours were removed using Mohs micrographic surgery (MMS) to obtain histopathological maps of the tumour boundaries.
METHODS: Twelve patients with aggressive BCC of mean diameter 16 mm (range 5-32) in the face were included in the study. The patients were subjected to bispectral fluorescence imaging within the 2 months prior to MMS. The fluorescence images and histopathological maps were aligned using image warping.
RESULTS: Five patients (42%) showed good agreement with the histopathological mapping and the remaining seven patients (58%) showed partial agreement. Bispectral investigation combining autofluorescence with protoporphyrin IX (PpIX) fluorescence generally yielded better agreement with the histopathological boundaries of the tumours compared with using only the PpIX fluorescence.
CONCLUSIONS: In this preliminary study the fluorescence has been compared with the histopathological tumour boundaries. The result implies that the technique can be applied as a useful tool for indicating tumour boundary of aggressive BCCs. Further refinement is needed to be able to indicate the exact tumour border.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16433801     DOI: 10.1111/j.1365-2133.2005.07035.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  Real-time absorption reduced surface fluorescence imaging.

Authors:  Bin Yang; James W Tunnell
Journal:  J Biomed Opt       Date:  2014-09       Impact factor: 3.170

2.  Tri-modal confocal mosaics detect residual invasive squamous cell carcinoma in Mohs surgical excisions.

Authors:  Dan Gareau; Anna Bar; Nicholas Snaveley; Ken Lee; Nathaniel Chen; Neil Swanson; Eric Simpson; Steve Jacques
Journal:  J Biomed Opt       Date:  2012-06       Impact factor: 3.170

3.  Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate.

Authors:  Christine B Warren; Sara Lohser; Lauren C Wene; Brian W Pogue; Philip L Bailin; Edward V Maytin
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

4.  Detection of basal cell carcinomas in Mohs excisions with fluorescence confocal mosaicing microscopy.

Authors:  J K Karen; D S Gareau; S W Dusza; M Tudisco; M Rajadhyaksha; K S Nehal
Journal:  Br J Dermatol       Date:  2009-03-30       Impact factor: 9.302

5.  Confocal mosaicing microscopy in skin excisions: a demonstration of rapid surgical pathology.

Authors:  D S Gareau; Y G Patel; Y Li; I Aranda; A C Halpern; K S Nehal; M Rajadhyaksha
Journal:  J Microsc       Date:  2009-01       Impact factor: 1.758

6.  Fiber-optic and articulating arm implementations of laminar optical tomography for clinical applications.

Authors:  Sean A Burgess; Désirée Ratner; Brenda R Chen; Elizabeth M C Hillman
Journal:  Biomed Opt Express       Date:  2010-09-02       Impact factor: 3.732

7.  Anti-Stokes fluorescence from endogenously formed protoporphyrin IX--implications for clinical multiphoton diagnostics.

Authors:  Despina Kantere; Stina Guldbrand; John Paoli; Mattias Goksör; Dag Hanstorp; Ann-Marie Wennberg; Maria Smedh; Marica B Ericson
Journal:  J Biophotonics       Date:  2012-09-19       Impact factor: 3.207

8.  Use of Protoporphyrin Fluorescence to Determine Clinical Target Volume for Non-melanotic Skin Cancers Treated with Primary Radiotherapy.

Authors:  Stephanie Casey; Lara Best; Olga Vujovic; Kevin Jordan; Barbara Fisher; Deborah Carey; Deborah Bourdeau; Edward Yu
Journal:  Cureus       Date:  2016-09-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.